News
Celcuity gets FDA nod for first-in-class breast cancer drug
Celcuity has won FDA approval for gedatolisib – its first product – as a treatment for patients with a particular form of breast cancer.
News
FDA clears at-home start dose for Alzheimer's drug Leqembi
The FDA has cleared Eisai and Biogen's Leqembi Iqlik subcutaneous injection as a starting dose, removing the need for regular infusion clinic visits.
News
NICE aims to cut funding for Amgen lung cancer drug Lumykras
Amgen's Lumykras will no longer be funded by the Cancer Drugs Fund for KRAS-mutated lung cancer, says NHS reimbursement authority NICE.
News
UK first in Europe to clear Boehringer's IPF drug Jascayd
Boehringer Ingelheim has won the first European approval for its new idiopathic pulmonary fibrosis (IPF) therapy, Jascayd, in the UK.
News
Otsuka's Voyxact faces rival as FDA okays Vera IgAN drug
Vera Therapeutics has won FDA approval for Trutakna, a BAFF/APRIL inhibitor for IgAN that will compete with Otsuka's recently-launched Voyxact.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
